Quick Answer
Wave Life Sciences Ltd. reported Total Assets of $638.50 million for the year ending 2025.
- Wave Life Sciences Ltd. showed an increase of +81.3% in Total Assets from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: $71.00 million | Q1 2016: $158.52 million | Q2 2016: $190.34 million | Q3 2016: $179.97 million | Q1 2017: $151.51 million | Q2 2017: $226.43 million | Q3 2017: $202.09 million | Q1 2018: $150.42 million | Q2 2018: $353.74 million | Q3 2018: $324.58 million | Q1 2019: $430.61 million | Q2 2019: $385.55 million | Q3 2019: $347.21 million | Q1 2020: $238.57 million | Q2 2020: $203.95 million | Q3 2020: $310.06 million | Q1 2021: $242.65 million | Q2 2021: $206.41 million | Q3 2021: $200.51 million | Q1 2022: $167.36 million | Q2 2022: $213.32 million | Q3 2022: $181.51 million | Q1 2023: $267.27 million | Q2 2023: $229.99 million | Q3 2023: $199.92 million | Q1 2024: $235.27 million | Q2 2024: $208.82 million | Q3 2024: $358.50 million | Q1 2025: $288.34 million | Q2 2025: $252.36 million | Q3 2025: $241.38 million.
- Over the full 12 years of available data (2014 to 2025), Wave Life Sciences Ltd.'s Total Assets has grown by 21,632.4%.
- Historical annual values: Fiscal year 2025: $638.50 million | Fiscal year 2024: $352.21 million | Fiscal year 2023: $274.95 million | Fiscal year 2022: $146.39 million | Fiscal year 2021: $207.01 million | Fiscal year 2020: $279.24 million | Fiscal year 2019: $284.25 million | Fiscal year 2018: $295.94 million | Fiscal year 2017: $181.84 million | Fiscal year 2016: $164.81 million | Fiscal year 2015: $165.42 million | Fiscal year 2014: $2.94 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: